Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bristol Myers Squibb
Biotech
FDA pushes back Cytokinetics' heart drug PDUFA to year-end
Cytokinetics has seen any potential approval for its experimental heart drug delayed by an extra three months.
Ben Adams
May 2, 2025 7:48am
M&A remains ‘top priority’ for pharmas in face of tariff threat
Apr 25, 2025 10:41am
A closer look at pharma's top R&D budgets
Apr 4, 2025 9:34am
Top 10 pharma R&D budgets in 2024
Mar 31, 2025 6:00am
Cell therapy biotech axes cancer trial, turns to autoimmune
Mar 19, 2025 5:35pm
BMS' MyoKardia scraps heart muscle pact with Fulcrum
Mar 5, 2025 5:30am
